Search
Search Results
##search.searchResults.foundPlural##
-
MOLECULAR MECHANISMS OF INHIBITOR DEVELOPMENT IN HEMOPHILIA Guest Editor: Giancarlo Costaman
3216PDF: 1608HTML: 422 -
-
CYTOMEGALOVIRUS REACTIVATION IN ADULT RECIPIENTS OF AUTOLOGOUS STEM CELL TRANSPLANTATION: A SINGLE CENTER EXPERIENCE
1539PDF: 875HTML: 975figures: 177table 1: 180table2: 179table3: 180 -
ASSESSMENT OF CONGENITAL NEUTROPENIA IN CHILDREN: COMMON CLINICAL SCENERIES AND CLUES FOR MANAGEMENT Assessment of congenital neutropenia in children
1971PDF: 1118HTML: 612 -
CLINICAL ASPECTS OF UNCOMPLICATED AND SEVERE MALARIA
7898PDF: 4087HTML: 7340 -
DE NOVO AND THERAPY-RELATED MYELODYSPLASTIC SYNDROMES: ANALOGIES AND DIFFERENCES DE NOVO AND THERAPY-RELATED MYELODYSPLASTIC SYNDROMES
1349HTML: 387PDF: 812 -
PATHOGENESIS OF MALARIA IN TISSUES AND BLOOD
4456PDF: 1914HTML: 17730 -
PROCALCITONIN AS A BIOMARKER OF BACTERIAL INFECTION IN SICKLE CELL VASO-OCCLUSIVE CRISIS.
2055PDF: 1040HTML: 15649COVER LETTER: 186 -
TOLL-LIKE RECEPTORS IN CHRONIC LYMPHOCYTIC LEUKEMIA
2556PDF: 858HTML: 17463Fig1 Caligaris: 166Fig.2 Caliga: 199 -
-
DONOR KIR3DL1/RECEPTOR HLA-BW4-80I COMBINATION REDUCES ACUTE LEUKEMIA RELAPSE AFTER UMBILICAL CORD BLOOD TRANSPLANTATION WITHOUT IN VITRO T-CELL DEPLETION KIR3DL1 with HLA-Bw4-80I reduces leukemia relapse
1345PDF: 522HTML: 194 -
TREATMENT OF ACUTE MYELOID LEUKEMIA WITH 20-30% BONE MARROW BLASTS
2783PDF: 1002HTML: 5516 -
TREATMENT RECOMMENDATIONS FOR CHRONIC MYELOID LEUKEMIA
3293PDF: 1459HTML: 3996 -
POST-TRANSPLANT RELAPSE IN ACUTE LEUKEMIA: COMPARATIVE VALUE OF MRD AND CHIMERISM.
678PDF: 365Suppl. Files: 117HTML: 109 -
THE ROLE OF WHITE BLOOD CELL COUNT IN PERIANAL PATHOLOGIES: A RETROSPECTIVE ANALYSIS OF HEMATOLOGIC MALIGNANCIES Role of white blood cell count in perianal pathologies
3029PDF: 1838HTML: 231 -
IMATINIB IN CHRONIC MYELOID LEUKEMIA: AN OVERVIEW
4705PDF: 2814HTML: 2275 -
-
GROUP-BASED TRAJECTORY MODELING OF PLATELET IN PATIENTS WITH APLASTIC ANEMIA: A STUDY BASED ON THE MIMIC DATABASE
981PDF: 982Suppl. Files: 631HTML: 117 -
CENTRAL NERVOUS SYSTEM INVOLVEMENT IN ADULT ACUTE LYMPHOBLASTIC LEUKEMIA: DIAGNOSTIC TOOLS, PROPHYLAXIS AND THERAPY
4038PDF: 1918HTML: 5220Table 1: 185 -
NOVEL DRUGS IN FOLLICULAR LYMPHOMA
4298PDF: 1483HTML: 1547Untitled: 224 -
SIMILARITIES OF ELDERLY AND THERAPY-RELATED AML
3564PDF: 876HTML: 6710 -
CONTINUOUS CULTURES OF PLASMODIUM FALCIPARUM ESTABLISHED IN TANZANIA FROM PATIENTS WITH ACUTE MALARIA In vitro Malaria cultures
1641PDF: 533HTML: 203 -
AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR HIGH-RISK ACUTE LYMPHOBLASTIC LEUKEMIA: NON-RANDOMIZED STUDY WITH A MAXIMUM FOLLOW-UP OF MORE THAN 22 YEARS
1529PDF: 899HTML: 1951Figure: 169Tables: 185ALL revision 1: 190response to reviewer: 180 -
COVID-19 IN CHILDREN AND ADOLESCENT: CHARACTERISTICS AND SPECIFICITIES IN IMMUNOCOMPETENT AND ONCOHEMATOLOGICAL PATIENTS COVID-19 IN CHILDREN AND ADOLESCENT.
2222PDF: 930HTML: 298 -
THE HISTORY OF DEFERIPRONE (L1) AND THE COMPLETE TREATMENT OF IRON OVERLOAD IN THALASSAEMIA The history and roles of deferiprone
2384PDF: 1579HTML: 616 -
SOCIOECONOMIC STATUS IS GLOBALLY A PROGNOSTIC FACTOR FOR OVERALL SURVIVAL OF MULTIPLE MYELOMA PATIENTS; SYNTHESIS OF STUDIES AND REVIEW OF THE LITERATURE SES as prognostic factor for myeloma survival
2016PDF: 817HTML: 208 -
-
MONITORING THE RESPONSE TO TYROSINE KINASE INHIBITOR (TKI) TREATMENT IN CHRONIC MYELOID LEUKEMIA (CML)
3919PDF: 1484HTML: 9187Untitled: 273Untitled: 177Untitled: 165Untitled: 161Untitled: 177Untitled: 334 -
THE PROTHROMBOTIC STATE ASSOCIATED WITH SARS-COV-2 INFECTION: PATHOPHYSIOLOGICAL ASPECTS COVID and Thrombosis
1947PDF: 809HTML: 219 -
COAGULOPATHY IN BETA-THALASSEMIA: CURRENT UNDERSTANDING AND FUTURE PERSPECTIVES
1083PDF: 485HTML: 8160







